Myungin Pharm AGM: Election of Inside Directors Lee and Cha, Articles Amendment
Regular general meeting convened (March 26, 2026, Hwaseong Factory) to approve financial statements, amend articles, elect directors among 5 agenda items.
Inside director candidates: Lee Gwan-sun (CEO of GID Partners, former Vice Chairman of Hanmi Pharm) and Cha Bong-kwon (President of Sales at Myungin Pharm) newly appointed.
Outside director audit committee member: Yoon Jun-seop (pharmacist, auditor of Coastech Chemon) reappointed.
Other items: audit report, business report, approval of director remuneration limit.
KOSPI Filing Information
Filing: Resolution To Convene A General Meeting Of Shareholders
Company: MYUNGIN PHARM (317450)
Submission: MYUNGIN PHARM.CO., LTD
Receipt: 02-03-2026
Under KRX KOSPI Market Division, Amended (Refer to related filing)